デフォルト表紙
市場調査レポート
商品コード
1701963

不妊検査市場:製品別、購入モード別、用途別、エンドユーザー別、地域別、2025-2033年

Fertility Test Market Report by Product, Mode of Purchase, Application, End User, and Region 2025-2033


出版日
発行
IMARC
ページ情報
英文 135 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
不妊検査市場:製品別、購入モード別、用途別、エンドユーザー別、地域別、2025-2033年
出版日: 2025年04月01日
発行: IMARC
ページ情報: 英文 135 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

不妊検査市場の世界市場規模は2024年に5億8,440万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに9億7,170万米ドルに達し、2025年から2033年にかけて5.52%の成長率(CAGR)を示すと予測しています。

不妊検査は、カップルの妊娠を妨げる問題を診断するために行われます。血液検査、骨盤内検査、精液分析、基礎体温(BBT)チャート、性交後検査、経膣(骨盤)超音波検査、子宮卵管造影(HSG)、子宮鏡検査、腹腔鏡検査で構成されます。これらは信頼性が高く、有効であり、適切な治療を決定するのに役立ちます。さらに、体内での性感染症(STI)の蔓延を防ぐ効果もあります。不妊検査は、子宮頸がんや子宮頸部周辺の異常細胞の発見にも役立ちます。そのため、病院、在宅医療、不妊治療クリニックなどで実施されています。

不妊検査市場傾向:

卵巣によるエストロゲンの過剰分泌に起因する多嚢胞性卵巣症候群(PCOS)などの疾患の有病率の増加は、市場を牽引する重要な要因の一つです。さらに、ライフスタイルの変化やストレスの増加、運動不足や食事パターンの変化による肥満が原因で、世界中で不妊率が上昇しています。これは、不妊検査の利点に関する大衆の意識の高まりとともに、市場の成長を後押ししています。さらに、大衆の間で不妊を治療するための技術的に高度な製品の発売は、市場にプラスの影響を与えています。これに加えて、主な市場プレイヤーは、すべての不妊関連データを一元化するための妊娠・排卵検査キットを導入するための研究開発(R&D)活動に幅広く投資しています。これは、急成長するヘルスケア産業と相まって、業界の投資家に有利な成長機会を提供しています。これとは別に、精度の高い使いやすい不妊治療モニターに対する需要も増加しています。精子分析における人工知能(AI)の活用の高まりは、市場の成長を後押しすると予想されます。

本レポートで扱う主な質問

  • 2024年の世界の不妊検査市場の市場規模は?
  • 2025-2033年の世界の不妊検査市場の予想成長率は?
  • 世界の不妊検査市場を牽引する主要因は何か?
  • 世界の不妊検査市場に対するCOVID-19の影響は?
  • 世界の不妊検査市場の製品別内訳は?
  • 世界の不妊検査市場の購入モード別の内訳は?
  • 世界の不妊検査市場の用途別の内訳は?
  • 世界の不妊検査市場のエンドユーザー別内訳は?
  • 世界の不妊検査市場における主要地域は?
  • 世界の不妊検査市場における主要プレイヤー/企業は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の不妊検査市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:製品別

  • 排卵予測キット
  • 妊娠検査モニター
  • 男性用不妊検査製品

第7章 市場内訳:購入モード別

  • OTCベース
  • 処方箋ベース

第8章 市場内訳:用途別

  • 女性用
  • 男性用

第9章 市場内訳:エンドユーザー別

  • 病院
  • 在宅医療
  • 不妊治療クリニック
  • その他

第10章 市場内訳:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳:国別

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • AdvaCare Pharma
    • Ava AG
    • Babystart Ltd.(Snowden Healthcare)
    • Church & Dwight Co. Inc.
    • Fairhaven Health LLC
    • Geratherm Medical AG
    • Prestige Consumer Healthcare Inc.
    • Quidel Corporation
    • UEBE Medical GmbH
    • Valley Electronics AG
    • viO HealthTech Limited
図表

List of Figures

  • Figure 1: Global: Fertility Test Market: Major Drivers and Challenges
  • Figure 2: Global: Fertility Test Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Fertility Test Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Fertility Test Market: Breakup by Mode of Purchase (in %), 2024
  • Figure 6: Global: Fertility Test Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Fertility Test Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Fertility Test Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Fertility Test (Ovulation Prediction Kits) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Fertility Test (Ovulation Prediction Kits) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Fertility Test (Fertility Monitors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Fertility Test (Fertility Monitors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Fertility Test (Male Fertility Testing Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Fertility Test (Male Fertility Testing Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Fertility Test (OTC-based) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Fertility Test (OTC-based) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Fertility Test (Prescription-based) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Fertility Test (Prescription-based) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Fertility Test (Female Fertility Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Fertility Test (Female Fertility Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Fertility Test (Male Fertility Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Fertility Test (Male Fertility Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Fertility Test (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Fertility Test (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Fertility Test (Home Care Settings) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Fertility Test (Home Care Settings) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Fertility Test (Fertility Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Fertility Test (Fertility Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Fertility Test (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Fertility Test (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: North America: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: North America: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: United States: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: United States: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Canada: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Canada: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Asia-Pacific: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Asia-Pacific: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: China: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: China: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Japan: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Japan: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: India: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: India: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: South Korea: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: South Korea: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Australia: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Australia: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Indonesia: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Indonesia: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Others: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Others: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Europe: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Europe: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Germany: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Germany: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: France: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: France: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: United Kingdom: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: United Kingdom: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Italy: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Italy: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Spain: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Spain: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Russia: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Russia: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Latin America: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Latin America: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Brazil: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Brazil: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Mexico: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Mexico: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Others: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Others: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Middle East and Africa: Fertility Test Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Middle East and Africa: Fertility Test Market: Breakup by Country (in %), 2024
  • Figure 79: Middle East and Africa: Fertility Test Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Global: Fertility Test Industry: SWOT Analysis
  • Figure 81: Global: Fertility Test Industry: Value Chain Analysis
  • Figure 82: Global: Fertility Test Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Fertility Test Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Fertility Test Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Fertility Test Market Forecast: Breakup by Mode of Purchase (in Million USD), 2025-2033
  • Table 4: Global: Fertility Test Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Fertility Test Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Fertility Test Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Fertility Test Market: Competitive Structure
  • Table 8: Global: Fertility Test Market: Key Players
目次
Product Code: SR112025A5810

The global fertility test market size reached USD 584.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 971.7 Million by 2033, exhibiting a growth rate (CAGR) of 5.52% during 2025-2033.

Fertility tests are performed to diagnose problems that prevent couples from conceiving. They comprise blood tests, pelvic examination, semen analysis, basal body temperature (BBT) charting, post coital test, transvaginal (pelvic) ultrasound exam, hysterosalpingogram or HSG, hysteroscopy, and laparoscopy. They are reliable, valid, and assist in determining a suitable treatment. In addition, they prevent the spread of sexually transmitted infections (STIs) in the body. Fertility tests also help detect cervical cancer and abnormal cells around the cervix. As a result, they are carried out in hospitals, home care, and fertility clinics.

Fertility Test Market Trends:

The growing prevalence of diseases, such as polycystic ovary syndrome (PCOS), due to the overproduction of estrogen by the ovaries represents one of the key factors driving the market. Moreover, there is a rise in infertility rates across the globe due to lifestyle changes and increasing stress and obesity, which is caused by a lack of physical exercise and alterations in dietary pattern. This, along with the increasing awareness among the masses about the benefits of fertility tests, is propelling the growth of the market. In addition, the launch of technologically advanced products to treat infertility among the masses is positively influencing the market. Besides this, key market players are extensively investing in research and development (R&D) activities to introduce pregnancy and ovulation test kits for centralizing all fertility-related data. This, coupled with the burgeoning healthcare industry, is offering lucrative growth opportunities to industry investors. Apart from this, there is an increase in the demand for easy-to-use fertility monitors with high accuracy. The rising utilization of artificial intelligence (AI) in sperm analysis is expected to bolster the growth of the market.

Key Market Segmentation:

Breakup by Product:

  • Ovulation Prediction Kits
  • Fertility Monitors
  • Male Fertility Testing Products

Breakup by Mode of Purchase:

  • OTC-based
  • Prescription-based

Breakup by Application:

  • Female Fertility Testing
  • Male Fertility Testing

Breakup by End User:

  • Hospitals
  • Home Care Settings
  • Fertility Clinics
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AdvaCare Pharma, Ava AG, Babystart Ltd. (Snowden Healthcare), Church & Dwight Co. Inc., Fairhaven Health LLC, Geratherm Medical AG, Prestige Consumer Healthcare Inc., Quidel Corporation, UEBE Medical GmbH, Valley Electronics AG and viO HealthTech Limited.

Key Questions Answered in This Report

  • 1.What was the size of the global fertility test market in 2024?
  • 2.What is the expected growth rate of the global fertility test market during 2025-2033?
  • 3.What are the key factors driving the global fertility test market?
  • 4.What has been the impact of COVID-19 on the global fertility test market?
  • 5.What is the breakup of the global fertility test market based on the product?
  • 6.What is the breakup of the global fertility test market based on the mode of purchase?
  • 7.What is the breakup of the global fertility test market based on the application?
  • 8.What is the breakup of the global fertility test market based on the end user?
  • 9.What are the key regions in the global fertility test market?
  • 10.Who are the key players/companies in the global fertility test market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Fertility Test Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Ovulation Prediction Kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Fertility Monitors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Male Fertility Testing Products
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Mode of Purchase

  • 7.1 OTC-based
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Prescription-based
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Female Fertility Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Male Fertility Testing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Home Care Settings
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Fertility Clinics
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 AdvaCare Pharma
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Ava AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Babystart Ltd. (Snowden Healthcare)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Church & Dwight Co. Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Fairhaven Health LLC
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Geratherm Medical AG
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Prestige Consumer Healthcare Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Quidel Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 UEBE Medical GmbH
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Valley Electronics AG
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 viO HealthTech Limited
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio